DAltri T, Freeberg M, Curwin A, Alonso A, Freitas A, Capella-Gutierrez S
Nat Genet. 2025; 57(3):481-485.
PMID: 40033058
DOI: 10.1038/s41588-025-02101-9.
Smith J, Wong Q, Hornsby W, Conomos M, Heavner B, Kullo I
ArXiv. 2025; .
PMID: 39990790
PMC: 11844628.
Corvi J, Diaz-Roussel N, Fernandez J, Ronzano F, Centeno E, Accuosto P
J Cheminform. 2025; 17(1):15.
PMID: 39901182
PMC: 11792311.
DOI: 10.1186/s13321-024-00925-x.
Su Y, Han Z, Ji Y, Liu A, Zou D, Yan L
Leukemia. 2025; .
PMID: 39894867
DOI: 10.1038/s41375-025-02514-9.
Frost H
bioRxiv. 2024; .
PMID: 39386631
PMC: 11463668.
DOI: 10.1101/2024.09.25.615040.
The Evolutionary Forest of Pancreatic Cancer.
Mullen K, Hong J, Attiyeh M, Hayashi A, Sakamoto H, Kohutek Z
Cancer Discov. 2024; 15(2):329-345.
PMID: 39378050
PMC: 11803399.
DOI: 10.1158/2159-8290.CD-23-1541.
An interconnected data infrastructure to support large-scale rare disease research.
Johansson L, Laurie S, Spalding D, Gibson S, Ruvolo D, Thomas C
Gigascience. 2024; 13.
PMID: 39302238
PMC: 11413801.
DOI: 10.1093/gigascience/giae058.
CHK1 inhibitor SRA737 is active in PARP inhibitor resistant and amplified ovarian cancer.
Xu H, Gitto S, Ho G, Medvedev S, Shield-Artin K, Kim H
iScience. 2024; 27(7):109978.
PMID: 39021796
PMC: 11253285.
DOI: 10.1016/j.isci.2024.109978.
Tackling neurodegeneration with omics: a path towards new targets and drugs.
Carraro C, Montgomery J, Klimmt J, Paquet D, Schultze J, Beyer M
Front Mol Neurosci. 2024; 17:1414886.
PMID: 38952421
PMC: 11215216.
DOI: 10.3389/fnmol.2024.1414886.
Low-coverage whole genome sequencing for a highly selective cohort of severe COVID-19 patients.
Santos R, Moreno-Torres V, Pintos I, Corral O, de Mendoza C, Soriano V
GigaByte. 2024; 2024:gigabyte127.
PMID: 38948510
PMC: 11211761.
DOI: 10.46471/gigabyte.127.
Aberrant spliceosome activity via elevated intron retention and upregulation and phosphorylation of SF3B1 in chronic lymphocytic leukemia.
Kashyap M, Karathia H, Kumar D, Vera Alvarez R, Forero-Forero J, Moreno E
Mol Ther Nucleic Acids. 2024; 35(2):102202.
PMID: 38846999
PMC: 11154714.
DOI: 10.1016/j.omtn.2024.102202.
Sharing sensitive data in life sciences: an overview of centralized and federated approaches.
Rujano M, Boiten J, Ohmann C, Canham S, Contrino S, David R
Brief Bioinform. 2024; 25(4).
PMID: 38836701
PMC: 11151787.
DOI: 10.1093/bib/bbae262.
Getting your DUCs in a row - standardising the representation of Digital Use Conditions.
Jeanson F, Gibson S, Alper P, Bernier A, Woolley J, Mietchen D
Sci Data. 2024; 11(1):464.
PMID: 38719839
PMC: 11078994.
DOI: 10.1038/s41597-024-03280-6.
Applied models and molecular characteristics of small cell lung cancer.
Mihalekne Fur G, Nemes K, Mago E, Beno A, Topolcsanyi P, Moldvay J
Pathol Oncol Res. 2024; 30:1611743.
PMID: 38711976
PMC: 11070512.
DOI: 10.3389/pore.2024.1611743.
Ensemble-based classification using microRNA expression identifies a breast cancer patient subgroup with an ultralow long-term risk of metastases.
Block I, Burton M, Sorensen K, Larsen M, Do T, Bak M
Cancer Med. 2024; 13(9):e7089.
PMID: 38676390
PMC: 11053369.
DOI: 10.1002/cam4.7089.
Chromatin accessibility profiling methods.
Minnoye L, Marinov G, Krausgruber T, Pan L, Marand A, Secchia S
Nat Rev Methods Primers. 2024; 1.
PMID: 38410680
PMC: 10895463.
DOI: 10.1038/s43586-020-00008-9.
Refined preferences of prioritizers improve intelligent diagnosis for Mendelian diseases.
Yuan X, Su J, Wang J, Dai B, Sun Y, Zhang K
Sci Rep. 2024; 14(1):2845.
PMID: 38310124
PMC: 10838329.
DOI: 10.1038/s41598-024-53461-x.
FAIR data retrieval for sensitive clinical research data in Galaxy.
Ouwerkerk J, Rasche H, Spalding J, Hiltemann S, Stubbs A
Gigascience. 2024; 13.
PMID: 38280189
PMC: 10821763.
DOI: 10.1093/gigascience/giad099.
Review of Computational Methods and Database Sources for Predicting the Effects of Coding Frameshift Small Insertion and Deletion Variations.
Ge F, Arif M, Yan Z, Alahmadi H, Worachartcheewan A, Shoombuatong W
ACS Omega. 2024; 9(2):2032-2047.
PMID: 38250421
PMC: 10795160.
DOI: 10.1021/acsomega.3c07662.
Inflammatory response signature score model for predicting immunotherapy response and pan-cancer prognosis.
Chen S, Huang M, Zhang L, Huang Q, Wang Y, Liang Y
Comput Struct Biotechnol J. 2024; 23:369-383.
PMID: 38226313
PMC: 10788202.
DOI: 10.1016/j.csbj.2023.12.001.